HLC-001

N/A

Report date: 2026/03/13 20:02:36

Base Information

Drug NameHLC-001
Drug Alias NameHLC-001
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Lung Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesHuman Life CORD Japan Inc
China Registration ClassN/A

Develop Information

Active CompaniesHuman Life CORD Japan Inc
Inactive CompaniesN/A
Active IndicationsLung Diseases
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A